• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基层医疗人群中慢性阻塞性肺疾病急性加重的危险因素:一项回顾性观察队列研究。

Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study.

作者信息

Müllerová Hana, Shukla Amit, Hawkins Adam, Quint Jennifer

机构信息

Worldwide Epidemiology, GlaxoSmithKline, Uxbridge, UK.

Global Respiratory Franchise, GlaxoSmithKline, Uxbridge, UK.

出版信息

BMJ Open. 2014 Dec 18;4(12):e006171. doi: 10.1136/bmjopen-2014-006171.

DOI:10.1136/bmjopen-2014-006171
PMID:25524545
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4275672/
Abstract

OBJECTIVES

To evaluate risk factors associated with exacerbation frequency in primary care. Information on exacerbations of chronic obstructive pulmonary disease (COPD) has mainly been generated by secondary care-based clinical cohorts.

DESIGN

Retrospective observational cohort study.

SETTING

Electronic medical records database (England and Wales).

PARTICIPANTS

58,589 patients with COPD aged ≥40 years with COPD diagnosis recorded between 1 April 2009 and 30 September 2012, and with at least 365 days of follow-up before and after the COPD diagnosis, were identified in the Clinical Practice Research Datalink. Mean age: 69 years; 47% female; mean forced expiratory volume in 1s 60% predicted.

OUTCOME MEASURES

Data on moderate or severe exacerbation episodes defined by diagnosis and/or medication codes 12 months following cohort entry were retrieved, together with demographic and clinical characteristics. Associations between patient characteristics and odds of having none versus one, none versus frequent (≥2) and one versus frequent exacerbations over 12 months follow-up were evaluated using multivariate logistic regression models.

RESULTS

During follow-up, 23% of patients had evidence of frequent moderate-to-severe COPD exacerbations (24% one; 53% none). Independent predictors of increased odds of having exacerbations during the follow-up, either frequent episodes or one episode, included prior exacerbations, increasing dyspnoea score, increasing grade of airflow limitation, females and prior or current history of several comorbidities (eg, asthma, depression, anxiety, heart failure and cancer).

CONCLUSIONS

Primary care-managed patients with COPD at the highest risk of exacerbations can be identified by exploring medical history for the presence of prior exacerbations, greater COPD disease severity and co-occurrence of other medical conditions.

摘要

目的

评估基层医疗中与急性加重频率相关的风险因素。慢性阻塞性肺疾病(COPD)急性加重的信息主要来自基于二级医疗的临床队列研究。

设计

回顾性观察性队列研究。

地点

电子病历数据库(英格兰和威尔士)。

参与者

在临床实践研究数据链中识别出58589例年龄≥40岁的COPD患者,这些患者在2009年4月1日至2012年9月30日期间有COPD诊断记录,且在COPD诊断前后至少有365天的随访。平均年龄:69岁;47%为女性;1秒用力呼气容积平均为预测值的60%。

观察指标

检索队列入组后12个月由诊断和/或用药编码定义的中度或重度急性加重发作的数据,以及人口统计学和临床特征。使用多变量逻辑回归模型评估患者特征与12个月随访期间无急性加重与有1次急性加重、无急性加重与频繁急性加重(≥2次)以及1次急性加重与频繁急性加重之间的关联。

结果

在随访期间,23%的患者有频繁中至重度COPD急性加重的证据(24%有1次;53%无)。随访期间急性加重发作频繁或发作1次几率增加的独立预测因素包括既往急性加重、呼吸困难评分增加、气流受限分级增加、女性以及既往或目前有多种合并症(如哮喘、抑郁、焦虑、心力衰竭和癌症)病史。

结论

通过探究病史中是否存在既往急性加重、更高的COPD疾病严重程度以及其他疾病的共病情况,可以识别出基层医疗管理的COPD患者中急性加重风险最高的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68f5/4275672/0033e6024353/bmjopen2014006171f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68f5/4275672/854c5d27c979/bmjopen2014006171f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68f5/4275672/40bb9a848ef7/bmjopen2014006171f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68f5/4275672/0033e6024353/bmjopen2014006171f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68f5/4275672/854c5d27c979/bmjopen2014006171f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68f5/4275672/40bb9a848ef7/bmjopen2014006171f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/68f5/4275672/0033e6024353/bmjopen2014006171f03.jpg

相似文献

1
Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study.基层医疗人群中慢性阻塞性肺疾病急性加重的危险因素:一项回顾性观察队列研究。
BMJ Open. 2014 Dec 18;4(12):e006171. doi: 10.1136/bmjopen-2014-006171.
2
What happens between first symptoms and first acute exacerbation of COPD - observational study of routine data and patient survey.COPD 首次症状与首次急性加重之间的情况 - 常规数据和患者调查的观察性研究。
Health Soc Care Deliv Res. 2024 Oct;12(43):1-80. doi: 10.3310/CGTR6370.
3
Prevalence and burden of breathlessness in patients with chronic obstructive pulmonary disease managed in primary care.慢性阻塞性肺疾病患者在初级保健中管理的呼吸困难患病率和负担。
PLoS One. 2014 Jan 10;9(1):e85540. doi: 10.1371/journal.pone.0085540. eCollection 2014.
4
Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records.慢性阻塞性肺疾病(COPD)患者社区获得性肺炎的季节性、危险因素及负担:一项使用关联医疗记录的人群数据库研究
Int J Chron Obstruct Pulmon Dis. 2017 Jan 17;12:313-322. doi: 10.2147/COPD.S121389. eCollection 2017.
5
Clinical Characteristics and Frequency of Chronic Obstructive Pulmonary Disease Exacerbations in Korean Patients: Findings From the KOCOSS Cohort 2012-2021.韩国患者慢性阻塞性肺疾病加重的临床特征和频率:来自 KOCOSS 队列 2012-2021 年的研究结果。
J Korean Med Sci. 2024 May 20;39(19):e164. doi: 10.3346/jkms.2024.39.e164.
6
Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK.在英国常规临床实践中,根据 GOLD A 和 B 对 COPD 患者进行分类,与首次加重相关的风险因素。
Int J Chron Obstruct Pulmon Dis. 2023 Nov 21;18:2673-2685. doi: 10.2147/COPD.S413947. eCollection 2023.
7
COPD management costs according to the frequency of COPD exacerbations in UK primary care.根据英国初级保健中 COPD 加重的频率来管理 COPD 的成本。
Int J Chron Obstruct Pulmon Dis. 2014;9:65-73. doi: 10.2147/COPD.S54417. Epub 2014 Jan 9.
8
Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.针对患有慢性阻塞性肺疾病和至少一种其他长期疾病的成年人的定制或改编干预措施:一项混合方法综述。
Cochrane Database Syst Rev. 2021 Jul 26;7(7):CD013384. doi: 10.1002/14651858.CD013384.pub2.
9
Exacerbation in patients with stable COPD in China: analysis of a prospective, 52-week, nationwide, observational cohort study (REAL).中国稳定期 COPD 患者的恶化:一项前瞻性、52 周、全国性、观察性队列研究(REAL)的分析。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231167353. doi: 10.1177/17534666231167353.
10
Predictors of exacerbations of asthma and COPD during one year in primary care.在初级保健中预测哮喘和 COPD 一年期间的恶化情况。
Fam Pract. 2013 Dec;30(6):621-8. doi: 10.1093/fampra/cmt055. Epub 2013 Oct 10.

引用本文的文献

1
Incidence, risk factors, and outcomes of respiratory related hospitalizations in older patients with COPD, asthma, and bronchiectasis.慢性阻塞性肺疾病(COPD)、哮喘和支气管扩张症老年患者呼吸道相关住院的发病率、危险因素及预后
Sci Rep. 2025 Jul 2;15(1):22580. doi: 10.1038/s41598-025-07197-x.
2
The clinical effectiveness of sodium-glucose co-transporter-2 inhibitors on prognosis of patients with chronic obstructive pulmonary disease and diabetes.钠-葡萄糖协同转运蛋白2抑制剂对慢性阻塞性肺疾病合并糖尿病患者预后的临床疗效
Nat Commun. 2025 Jul 1;16(1):5478. doi: 10.1038/s41467-025-60582-y.
3
Chronic Obstructive Pulmonary Disease and the Management of Cardiopulmonary Risk in the UK: A Systematic Literature Review and Modified Delphi Study.

本文引用的文献

1
Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource.以普通实践研究数据库为例,简述英国初级保健数据资源的效用和使用方面的最新进展。
Ther Adv Drug Saf. 2012 Apr;3(2):89-99. doi: 10.1177/2042098611435911.
2
Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects.系统综述霍桑效应:需要新的概念来研究研究参与效应。
J Clin Epidemiol. 2014 Mar;67(3):267-77. doi: 10.1016/j.jclinepi.2013.08.015. Epub 2013 Nov 22.
3
Exploiting the potential of large databases of electronic health records for research using rapid search algorithms and an intuitive query interface.
慢性阻塞性肺疾病与英国心肺风险的管理:一项系统文献综述及改良德尔菲研究
Int J Chron Obstruct Pulmon Dis. 2025 Jun 25;20:2073-2090. doi: 10.2147/COPD.S523865. eCollection 2025.
4
Clinical characteristic of patients with COPD-A.慢性阻塞性肺疾病A组患者的临床特征。
BMC Pulm Med. 2025 May 23;25(1):260. doi: 10.1186/s12890-025-03731-9.
5
ANMCO position paper: diagnosis and treatment of heart failure with preserved systolic function.意大利心脏病学国家协会立场文件:射血分数保留的心力衰竭的诊断与治疗
Eur Heart J Suppl. 2025 May 15;27(Suppl 5):v216-v246. doi: 10.1093/eurheartjsupp/suaf070. eCollection 2025 May.
6
Step up to triple therapy versus switch to dual bronchodilator therapy in patients with COPD on an inhaled corticosteroid/long-acting β-agonist: post-hoc analyses of KRONOS.慢性阻塞性肺疾病(COPD)患者在吸入性糖皮质激素/长效β受体激动剂治疗基础上,升级至三联疗法与换用双支气管扩张剂疗法的比较:KRONOS研究的事后分析
Respir Res. 2025 May 8;26(1):175. doi: 10.1186/s12931-025-03234-5.
7
Disproportionately raised risk of adverse outcomes in patients with COPD and comorbid type 2 diabetes or depression: Swedish register-based cohort study.慢性阻塞性肺疾病(COPD)合并2型糖尿病或抑郁症患者不良结局风险不成比例增加:基于瑞典登记册的队列研究。
Respir Res. 2025 Mar 5;26(1):84. doi: 10.1186/s12931-025-03160-6.
8
A Delphi Consensus Project to Capture Greek Experts' Opinion on the Position of Triple Therapies in COPD: Why, When and to Whom.一项德尔菲共识项目,旨在收集希腊专家对慢性阻塞性肺疾病三联疗法的应用立场的意见:为何、何时以及适用于何人。
Int J Chron Obstruct Pulmon Dis. 2025 Feb 26;20:457-471. doi: 10.2147/COPD.S481337. eCollection 2025.
9
Is Disease Stability an Attainable Chronic Obstructive Pulmonary Disease Treatment Goal?疾病稳定是慢性阻塞性肺疾病可实现的治疗目标吗?
Am J Respir Crit Care Med. 2025 Mar;211(3):452-463. doi: 10.1164/rccm.202406-1254CI.
10
An Italian Delphi Consensus on the Triple inhalation Therapy in Chronic Obstructive Pulmonary Disease.意大利慢性阻塞性肺疾病三联吸入疗法德尔菲共识
Multidiscip Respir Med. 2024 Sep 18;19(1):949. doi: 10.5826/mrm.2024.949.
利用电子健康记录的大型数据库的潜力,通过快速搜索算法和直观的查询界面进行研究。
J Am Med Inform Assoc. 2014 Mar-Apr;21(2):292-8. doi: 10.1136/amiajnl-2013-001847. Epub 2013 Nov 22.
4
Representativeness and optimal use of body mass index (BMI) in the UK Clinical Practice Research Datalink (CPRD).英国临床实践研究数据库(CPRD)中体重指数(BMI)的代表性和最佳使用。
BMJ Open. 2013 Sep 13;3(9):e003389. doi: 10.1136/bmjopen-2013-003389.
5
Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease.慢性阻塞性肺疾病频繁加重表型的机制和影响。
BMC Med. 2013 Aug 14;11:181. doi: 10.1186/1741-7015-11-181.
6
Patient-reported outcome (PRO) measures for clinical trials of COPD: the EXACT and E-RS.用于 COPD 临床试验的患者报告结局(PRO)测量:EXACT 和 E-RS。
COPD. 2013 Jun;10(3):393-8. doi: 10.3109/15412555.2013.795423.
7
The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle-aged and elderly people from the general population.哮喘与慢性阻塞性肺疾病(COPD)共存:一般人群中年轻人、中年人和老年人的患病率和危险因素。
PLoS One. 2013 May 10;8(5):e62985. doi: 10.1371/journal.pone.0062985. Print 2013.
8
Acute exacerbations of COPD in the United States: inpatient burden and predictors of costs and mortality.美国慢性阻塞性肺疾病急性加重:住院负担以及费用和死亡率的预测因素。
COPD. 2012 Apr;9(2):131-41. doi: 10.3109/15412555.2011.650239. Epub 2012 Mar 12.
9
The Asthma-COPD Overlap Syndrome: A Common Clinical Problem in the Elderly.哮喘-慢性阻塞性肺疾病重叠综合征:老年人常见的临床问题
J Allergy (Cairo). 2011;2011:861926. doi: 10.1155/2011/861926. Epub 2011 Oct 30.
10
Time course and pattern of COPD exacerbation onset.COPD 加重发作的时间进程和模式。
Thorax. 2012 Mar;67(3):238-43. doi: 10.1136/thoraxjnl-2011-200768. Epub 2011 Oct 18.